RETA Historical PE Ratio image   This RETA PE ratio history page last updated 8/28/2023
RETA Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2023
8/8/2023
167.16-1.58-6.32NA
Q1 2023
5/10/2023
90.38-1.81-7.24NA
Q4 2022
2/24/2023
44.51-2.33-9.32NA
Q3 2022
11/8/2022
40.29-1.47-5.88NA
Q2 2022
8/8/2022
24.06-1.36-5.44NA
Q1 2022
5/10/2022
24.42-1.33-5.32NA
Q4 2021
2/28/2022
32.74-1.59-6.36NA
Q3 2021
11/8/2021
107.08-1.27-5.08NA
Q2 2021
8/9/2021
122.13-1.32-5.28NA
Q1 2021
5/6/2021
93.28-1.16-4.64NA
Q4 2020
3/1/2021
126.63-1.25-5.00NA
Q3 2020
11/9/2020
174.66-1.31-5.24NA
Q2 2020
8/10/2020
104.41-1.23-4.92NA
Q1 2020
5/11/2020
164.31-1.47-5.88NA
Q4 2019
2/19/2020
224.03-1.59-6.36NA
Q3 2019
11/12/2019
182.83-1.32-5.28NA
Q2 2019
8/8/2019
82.01-1.14-4.56NA
Q1 2019
5/9/2019
87.32-0.98-3.92NA
Q4 2018
2/28/2019
94.34-0.86-3.44NA
Q3 2018
11/7/2018
71.28-1.07-4.28NA
Q2 2018
8/8/2018
72.78-1.08-4.32NA
Q1 2018
5/8/2018
27.590.150.6046.0
Q4 2017
3/2/2018
21.91-0.64-2.56NA
Q3 2017
11/13/2017
25.19-0.50-2.00NA
Q2 2017
8/14/2017
27.44-0.52-2.08NA
Q1 2017
5/11/2017
22.30-0.32-1.28NA
Q4 2016
3/3/2017
28.89-0.19-0.76NA
Q3 2016
11/14/2016
36.11-0.04-0.16NA
Q2 2016
8/11/2016
15.85-0.05-0.20NA
RETA PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2023
8/8/2023
167.16-1.58-7.19NA
Q1 2023
5/10/2023
90.38-1.81-6.97NA
Q4 2022
2/24/2023
44.51-2.33-6.49NA
Q3 2022
11/8/2022
40.29-1.47-5.75NA
Q2 2022
8/8/2022
24.06-1.36-5.55NA
Q1 2022
5/10/2022
24.42-1.33-5.51NA
Q4 2021
2/28/2022
32.74-1.59-5.34NA
Q3 2021
11/8/2021
107.08-1.27-5.00NA
Q2 2021
8/9/2021
122.13-1.32-5.04NA
Q1 2021
5/6/2021
93.28-1.16-4.95NA
Q4 2020
3/1/2021
126.63-1.25-5.26NA
Q3 2020
11/9/2020
174.66-1.31-5.60NA
Q2 2020
8/10/2020
104.41-1.23-5.61NA
Q1 2020
5/11/2020
164.31-1.47-5.52NA
Q4 2019
2/19/2020
224.03-1.59-5.03NA
Q3 2019
11/12/2019
182.83-1.32-4.30NA
Q2 2019
8/8/2019
82.01-1.14-4.05NA
Q1 2019
5/9/2019
87.32-0.98-3.99NA
Q4 2018
2/28/2019
94.34-0.86-2.86NA
Q3 2018
11/7/2018
71.28-1.07-2.64NA
Q2 2018
8/8/2018
72.78-1.08-2.07NA
Q1 2018
5/8/2018
27.590.15-1.51NA
Q4 2017
3/2/2018
21.91-0.64-1.98NA
Q3 2017
11/13/2017
25.19-0.50-1.53NA
Q2 2017
8/14/2017
27.44-0.52-1.07NA
Q1 2017
5/11/2017
22.30-0.32-0.60NA
Q4 2016
3/3/2017
28.89-0.19NANA
Q3 2016
11/14/2016
36.11-0.04NANA
Q2 2016
8/11/2016
15.85-0.05NANA
Quotes delayed 20 minutes

Email EnvelopeFree RETA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Reata Pharmaceuticals (RETA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RGEN PE Ratio History
RGLS PE Ratio History
RGNX PE Ratio History
RIGL PE Ratio History
RLAY PE Ratio History
RLMD PE Ratio History
RLYB PE Ratio History
RMD PE Ratio History
RMED PE Ratio History
RMTI PE Ratio History
How should the RETA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Reata Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RETA Historical PE Ratio page.

What is the average historical PE for RETA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RETA historical PE ratio using the annualized quarterly earnings method works out to 46.0.

What is the average historical PE for RETA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RETA historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the RETA Historical PE Ratio information for Reata Pharmaceuticals' stock. The average RETA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 46.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RETA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RETA historical PE result, against the recent PE: when this page was posted on 8/25/2023, the most recent closing price for RETA had been 169.00, and the most recent quarterly earnings result, annualized, was 0.6. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent RETA PE on 8/25/2023 based on annualized quarterly EPS was 281.7. Based on RETA's history, that recent PE is elevated relative to the historical average, with the recent PE 512.4% higher than the historical average PE across our data set for Reata Pharmaceuticals.

For self directed investors doing their due diligence on RETA or any other given stock, valuation analysis for RETA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Reata Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RETA. Thanks for visiting, and the next time you need to research RETA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: NCS Videos, Funds Holding QSPT, LANC Options Chain.

 

RETA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.